Matches in Nanopublications for { ?s ?p "[Upregulation of the ERK1 and ERK2 (ERK1/2) MAP kinase (MAPK) cascade occurs in >30% of cancers, often through mutational activation of receptor tyrosine kinases or other upstream genes, including KRAS and BRAF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP890068.RAYaEb9uxHXLaOuZqLpYN0LhhsGTRm9-Qy70rNP8PvOg0130_assertion description "[Upregulation of the ERK1 and ERK2 (ERK1/2) MAP kinase (MAPK) cascade occurs in >30% of cancers, often through mutational activation of receptor tyrosine kinases or other upstream genes, including KRAS and BRAF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890068.RAYaEb9uxHXLaOuZqLpYN0LhhsGTRm9-Qy70rNP8PvOg0130_provenance.
- NP644777.RAJb6w0VrWtQmB1WySnWJVO5OyaB-Vb_-m8MgJ2z5LFSI130_assertion description "[Upregulation of the ERK1 and ERK2 (ERK1/2) MAP kinase (MAPK) cascade occurs in >30% of cancers, often through mutational activation of receptor tyrosine kinases or other upstream genes, including KRAS and BRAF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644777.RAJb6w0VrWtQmB1WySnWJVO5OyaB-Vb_-m8MgJ2z5LFSI130_provenance.